Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Adams Drops Compellent Technologies (CML) to Sell
-
Canaccord Adams Downgrades QLogic (QLGC) to Hold
-
Daily State of the Markets 4/8: Getting Their Due
-
Canaccord Adams Downgrades Emulex (ELX) from Top Pick to Hold; Valuation Call
-
Canaccord Adams Downgrades EMC Corp (EMC) to Hold
-
Canaccord Adams Maintains a 'Hold' on Monsanto (MON); Lowers PT
-
Canaccord Adams Initiates Coverage on Avanir Pharmaceuticals (AVNR) with a Buy; Zenvia Approval Seen in 2010
-
Canaccord Adams Maintains a 'Speculative Buy'on AEterna Zentaris (AEZS); Positive FDA Data From Partner Keryx Pharmaceuticals (KERX)
-
Canaccord Adams Raises Target On Apple (AAPL) to $300, Thinks 700K iPads Sold So Far
-
Canaccord Adams Downgrades Cameco (CCJ) to Sell
-
Canaccord Starts Sonic Solutions (SNIC) With 'Speculative Buy'; Key Enabler of "Digital Sell-Through" in Front of Major Product Cycle
-
Canaccord Adams Starts Sonic Solutions (SNIC) at 'Speculative Buy'
-
Canaccord Adams Lifts Price Target on BPZ Energy (BPZ) to $13
-
Canaccord Adams Maintains Bulllish Stance On Research In Motion (RIMM) Despite Disappointing Q1
-
Q4 Earnings Preview: Research in Motion (RIMM)
-
Canaccord Adams Maintains a 'Buy' on Myriad Genetics (MYGN); Lowers PT
-
Vale (VALE) Shares Rising Amid Canaccord Upgrade
-
Daily State of the Markets 3/29: That Sinking Feeling
-
Canaccord Adams Initiates Coverage on American Oil & Gas (AEZ) with a Buy; Material Catalysts on the Horizon
-
Canaccord Adams Maintains a 'Buy' on Schnitzer Steel (SCHN); Accumulate Ahead of Earnings Report
-
Canaccord Adams Maintains a 'Buy' on LSB Industries (LXU); Adjusting Estimates
-
Canaccord Adams Upgrades Netezza (NZ) to Buy; Growing Comfort Around Revenue Momentum
-
Canaccord Adams Reiterates a 'Buy' on Magnum Hunter Resources (MHR); Marcellus Wells Provide 2010 Catalysts
-
Canaccord Adams Maintains a 'Hold' Rating on Trex Company (TREX) After Visit to Headquarters
-
Canaccord Adams Maintains a 'Hold' Rating on Eldorado Gold (EGO); Lowers PT
-
Canaccord Adams Reiterates a 'Buy' on Herbalife (HLF); Plenty of Growth Drivers; Raises PT
-
Wall Street Weighs In On Palm's (PALM) Disastrous Report - Two Say It's Worth $0, Another Highlights Growing Chance of a Takeover
-
Earnings Preview: Palm (PALM) - From Goat to Hero, from Hero to Goat
-
Hercules Technology Growth (HTGC) Announces Committment of $52M in Debt Financing to Portfolio Co.'s
-
Canaccord Adams Initiates Coverage on Range Resources (RRC) with a Buy; One of The Best Large Shale Gas Explorers/Developers
-
Valuing Apple (AAPL): Upside Seen to $300 Per Share
-
Canaccord Adams Reiterates a 'Buy' on ATP Oil & Gas Corporation (ATPG); We Would Be Buyers
-
Canaccord Adams Downgraded GMX Resources (GMXR) to Hold; Downtrend Continues
-
Canaccord Adams & Morgan Keegan Downgrade GMX Resources (GMXR)
-
Canaccord Adams Maintains a 'Buy/Best Idea' Rating on Metalico (MEA); Raises PT & 2010 EPS Estimates
-
Canaccord Adams Maintains a 'Buy' on Obagi Medical Products (OMPI); Still Best Idea
-
Canaccord Adams Reiterates a 'Buy' on Constant Contact (CTCT); Still Best Idea; Build Position At Current Levels
-
Notable Analyst Rating Changes 03/12: ARO, NSM, CBEY, SCCO, TVL Upgraded; HBC, NRG, NFLX, SKIL, PSUN, SAAS Downgraded
-
AVEO Pharmaceuticals (AVEO) IPO Trades Lower
-
Daily State of the Markets 3/12: Follow the (New) Leader?
-
AVEO Pharma (AVEO) Prices 9M Common IPO at $9/Share
-
Canaccord Adams Reiterates a 'Buy' on SunOpta (STKL); Raises PT
-
Canaccord Adams Reiterates a 'Buy' on Semtech (SMTC); Raises Estimates
-
Canaccord Adams Reiterates a 'Buy' Rating on Approach Resources (AREX)
-
Canaccord Adams Reinstates a 'Buy' on Suncor Energy (SU), Adjusts PT & Estimates
-
Analysts Giddy About InterMune (ITMN) On Expected Pirfenidone Approval
-
Canaccord Adams Reiterates a 'Buy' on ICF International (ICFI); Strong Q4 Results; Maintain 2010 Estimates
-
Canaccord Adams Reiterates a 'Buy' on InterMune (ITMN); FDA Approval, Focus Shifts to Market Opportunity
-
Canaccord Adams Initiates Coverage on Netflix (NFLX) with a Buy; DVD-by-Mail Isn't Going Away
-
Canaccord Adams Initiates Coverage on Coinstar (CSTR) with a Buy
